Santen Pharmaceutical Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 390,000 | 0.11% |
Public Companies | 6,204,000 | 1.74% |
State or Government | 7,155,000 | 2.01% |
General Public | 138,867,599 | 39% |
Institutions | 203,475,175 | 57.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,839,347 | JP¥35.2b | 0% | 2.72% | |||
19,140,800 | JP¥32.4b | -16.5% | 0.07% | |||
18,733,186 | JP¥31.7b | 28% | 0.04% | |||
18,290,500 | JP¥30.9b | 33.7% | 0.71% | |||
13,977,717 | JP¥23.6b | 50% | 0.54% | |||
11,338,800 | JP¥19.2b | 0% | 0.08% | |||
11,079,451 | JP¥18.7b | 1.05% | no data | |||
10,662,000 | JP¥18.0b | 0% | 0.12% | |||
10,134,100 | JP¥17.1b | -18.7% | 0.11% | |||
9,041,567 | JP¥15.3b | 0% | 0.01% | |||
8,202,700 | JP¥13.9b | 0% | 0.03% | |||
7,155,000 | JP¥12.1b | -5.94% | no data | |||
6,863,000 | JP¥11.6b | 0% | no data | |||
6,292,258 | JP¥10.6b | -0.32% | no data | |||
6,204,000 | JP¥10.5b | 0% | no data | |||
4,946,500 | JP¥8.4b | -3.62% | 0.04% | |||
2,665,013 | JP¥4.5b | -19.5% | 0.01% | |||
2,453,020 | JP¥4.1b | 12.1% | no data | |||
2,263,700 | JP¥3.8b | -20.8% | 0.01% | |||
1,816,467 | JP¥3.1b | 2.24% | no data | |||
1,749,700 | JP¥3.0b | -3.93% | 0.02% | |||
1,562,600 | JP¥2.6b | -0.13% | 0.3% | |||
1,412,500 | JP¥2.4b | 0% | 0.15% | |||
1,128,216 | JP¥1.9b | -18.3% | 0.01% | |||
1,118,100 | JP¥1.9b | 31.8% | 0.02% |